Hereditary medullary thyroid cancer

被引：0
|
作者：
Fendrich, V. [1 ,2 ]
Zahn, A. [1 ]
机构：
[1] Schon Klin Eilbek, Klin Endokrine Chirurg, Hamburg, Germany
[2] Schon Klin Eilbek, Klin Endokrine Chirurg, Dehnhaide 120, D-22081 Hamburg, Germany
来源：
CHIRURGIE | 2023年 / 94卷 / 05期
关键词：
Genotype-phenotype correlation; MEN2; Calcitonin; RET proto-oncogene; Prophylactic thyroidectomy; SURGICAL-MANAGEMENT; CALCITONIN;
D O I：
10.1007/s00104-023-01824-x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Parafollicular C cells progress via C cell hyperplasia to medullary thyroid cancer (MTC), which can be present even in the first years of life in multiple endocrine neoplasia (MEN) type 2A and 2B patients. Basal calcitonin and carcinoembryonic antigen (CEA) are useful tumor markers for the diagnosis and monitoring. The prognosis depends on the stage when the disease is diagnosed and there is a good genotype-phenotype correlation with the RET proto-oncogene, which can be used for estimation of the risk. The risk-stratified prophylactic thyroidectomy plays a decisive role in the prognosis of known gene mutation carriers.
引用
收藏
页码：393 / 399
页数：7
相关论文
共 50 条
  • [31] Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer
    Patocs, Attila
    Klein, Izabella
    Szilvasi, Aniko
    Gergics, Peter
    Toth, Miklos
    Valkusz, Zsuzsa
    Forizs, Erzsebet
    Igaz, Peter
    Al-Farhat, Yousuf
    Tordai, Attila
    Varadi, Andras
    Racz, Karoly
    Esik, Olga
    WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (13-14) : 417 - 421
  • [32] Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
    Wells, Samuel A., Jr.
    Gosnell, Jessica E.
    Gagel, Robert F.
    Moley, Jeffrey
    Pfister, David
    Sosa, Julie A.
    Skinner, Michael
    Krebs, Annetta
    Vasselli, James
    Schlumberger, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 767 - 772
  • [33] MANAGEMENT OF HEREDITARY MEDULLARY-THYROID CARCINOMA
    BAYLIN, SB
    WELLS, SA
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1981, 10 (02): : 367 - 378
  • [34] Medullary thyroid cancer
    Kissin, A
    Batheja, N
    THYROID, 2000, 10 (03) : 281 - 281
  • [35] Medullary thyroid cancer
    Clayman, GL
    El-Baradie, TS
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2003, 36 (01) : 91 - +
  • [36] Medullary thyroid cancer
    You, Y. Nancy
    Lakhani, Vipul
    Wells, Samuel A., Jr.
    Moley, Jeffrey F.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 15 (03) : 639 - +
  • [37] MEDULLARY CANCER OF THE THYROID
    GOSSOT, D
    DUBOST, C
    SARFATI, E
    GAZETTE MEDICALE, 1987, 94 (12): : 59 - &
  • [38] Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities
    Machens, A.
    Lorenz, K.
    Dralle, H.
    JOURNAL OF INTERNAL MEDICINE, 2009, 266 (01) : 114 - 125
  • [39] Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer
    Scollo, C
    Baudin, E
    Travagli, JP
    Caillou, B
    Bellon, N
    Leboulleux, S
    Schlumberger, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05): : 2070 - 2075
  • [40] Increased Risk of Lymph Node Metastasis in Multifocal Hereditary and Sporadic Medullary Thyroid Cancer
    Andreas Machens
    Steffen Hauptmann
    Henning Dralle
    World Journal of Surgery, 2007, 31 : 1960 - 1965
12345